Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium-Reference-Cited by-同舟云学术

Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

Published:2018-09 Issue:9 Volume:113 Page:1345
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:American Journal of Gastroenterology

Author:

Narula Neeraj,Peerani Farhad,Meserve Joseph,Kochhar Gursimran,Chaudrey Khadija,Hartke Justin,Chilukuri Prianka,Koliani-Pace Jenna,Winters Adam,Katta Leah,Shmidt Eugenia,Hirten Robert,Faleck David,Parikh Malav P.,Whitehead Diana,Boland Brigid S.,Singh Siddharth,Sagi Sashidhar Varma,Fischer Monika,Chang Shannon,Barocas Morris,Luo Michelle,Lasch Karen,Bohm Matthew,Lukin Dana,Sultan Keith,Swaminath Arun,Hudesman David,Gupta Nitin,Shen Bo,Kane Sunanda,Loftus Edward V.,Siegel Corey A.,Sands Bruce E.,Colombel Jean-Frederic,Sandborn William J.,Dulai Parambir S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/s41395-018-0162-0.pdf

Reference22 articles.

1. Targeting TNF-α for the treatment of inflammatory bowel disease

2. Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD

3. Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

4. The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium

5. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis: Evidence from a systematic literature review;Journal of Managed Care & Specialty Pharmacy;2024-09

2. Implications of von Willebrand Factor in Inflammatory Bowel Diseases: Beyond Bleeding and Thrombosis;Inflammatory Bowel Diseases;2024-07-03

3. Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry;Alimentary Pharmacology & Therapeutics;2024-06-28

4. Approach to loss of response to advanced therapies in inflammatory bowel disease;World Journal of Gastroenterology;2024-06-14

5. Association between vedolizumab and risk of clostridium difficile infection in patients with ulcerative colitis: A systematic review and meta-analysis;Saudi Journal of Gastroenterology;2024-06-07